Data & AI

Dengue Policy Goes Regional

Schizophrenia’s Missing Symptoms Move Onto the Phone

Plague Never Left.

Roche’s Nearly $2B Atavistik Bet Goes After Cardiometabolic Targets Other Drugs Struggle to Reach

Clearing Amyloid Is Not the Same as Saving Cognition

The App Wasn’t Enough: Nurse-Led Digital Diabetes Care Linked to Better HbA1c and Adherence

Novo’s $1.4B Orbis Deal Bets on a New Route to Oral Cardiometabolic Drugs

Can Belgium Turn Routine GP Data Into Cardiovascular Prevention?

The healthcare AI race is shifting from smarter models to safer deployment
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
